Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

Ying, Haoqiang, Kimmelman, Alec C., Lyssiotis, Costas A., Hua, Sujun, Chu, Gerald C., Fletcher-Sananikone, Eliot, Locasale, Jason W., Son, Jaekyoung +23 more·2012·Cell

Cited by (1,006)

Items 801–900 of 1,006

  1. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy
    Xudong Xie, Hongpei Wu, Mei Li, Xiaojun Chen, XU Xiao-yun, Wenkai Ni, Cuihua Lu, Runzhou Ni, Baijun Bao, Mingbing Xiao · 2019 · Cytotherapy
  2. GFAT1/HBP/O‐GlcNAcylation Axis Regulates β ‐Catenin Activity to Promote Pancreatic Cancer Aggressiveness
    Chunzeng Jia, Hengchao Li, Deliang Fu, Yu Lan · 2020 · BioMed Research International
  3. Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
    Sayani Patra, Naveed Elahi, Aaron Armorer, Swathi Arunachalam, Joshua Omala, Iman Hamid, Anthony W. Ashton, David A. Joyce, Xuanmao Jiao, Richard G. Pestell · 2021 · Frontiers in Oncology
  4. NO<sup>•</sup>/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer
    Wang, Limin, Tang, Wei, Yang, Shouhui, He, Peijun, Wang, Jian, Gaedcke, Jochen, Ströbel, Philipp, Azizian, Azadeh, Ried, Thomas, Gaida, Matthias M. et al. · 2020 · International Journal of Cancer
  5. Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
    Anthony Turpin, Cindy Neuzillet, Elise Colle, Nelson Dusetti, Rémy Nicolle, Jerome F. Cros, Louis de Mestier, Jean‐Baptiste Bachet, Pascal R. Hammel · 2022 · Therapeutic Advances in Medical Oncology
  6. Mapping cancer cell metabolism with 13 C flux analysis: Recent progress and future challenges
    JameyDale Young, CaseyScott Duckwall, Taylor A. Murphy · 2013 · Journal of Carcinogenesis
  7. Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
    Zehua Zhu, Hadrien G. Golay, David Allen Barbie · 2014 · Pharmacogenomics
  8. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification
    Yuan Seng Wu, Chung Yeng Looi, Kavita S. Subramaniam, Atsushi Masamune, Ivy Chung · 2016 · Oncotarget
  9. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
    Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu et al. · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  10. Energy sources identify metabolic phenotypes in pancreatic cancer
    Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu et al. · 2016 · Acta Biochimica et Biophysica Sinica
  11. PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription
    Wenbo Zhang, Ying Xu, Qinggang Xu, Haifeng Shi, Juanjuan Shi, Yongzhong Hou · 2017 · Carcinogenesis
  12. Challenges in Ras therapeutics in pancreatic cancer
    Minsig Choi, Harold Bien, Adaobi Mofunanya, Scott Powers · 2017 · Seminars in Cancer Biology
  13. Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain
    Yu‐Ting Chou, Jeng‐Kai Jiang, Muh‐Hwa Yang, Jeng‐Wei Lu, Hua-Kuo Lin, Horng‐Dar Wang, Chiou‐Hwa Yuh · 2018 · PLoS Biology
  14. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways
    Claudia Fumarola, Pier Giorgio Petronini, Roberta R Alfieri · 2018 · Biochemical Pharmacology
  15. Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non–small‐cell lung cancer cells
    Wenshu Chen, C. Kieu, Bryanna Saxton, Shuguang Leng, Piotr Teodor Filipczak, Mathewos Tessema, Steven A. Belinsky, Yong Lin · 2019 · Molecular Carcinogenesis
  16. Oncogenic KRAS signaling activates mTORC1 through COUP‐TFII‐mediated lactate production
    Jun‐Kyu Byun, Mihyang Park, Jae Won Yun, Jaebon Lee, Jae Sun Kim, Sung Jin Cho, You Mie Lee, In‐Kyu Lee, Yeon‐Kyung Choi, Keun‐Gyu Park · 2019 · EMBO Reports
  17. Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma
    Hexige Saiyin, Christine Ardito-Abraham, Yanhua Wu, Youheng Wei, Yuan Fang, Xu Han, Jianang Li, Ping Zhou, Yi Qing, Anirban Maitra et al. · 2015 · The Journal of Pathology
  18. Molecular imaging of the tumor microenvironment reveals the relationship between tumor oxygenation, glucose uptake, and glycolysis in pancreatic ductal adenocarcinoma
    Yamamoto, Kazutoshi, Brender, Jeffrey R., Seki, Tomohiro, Kishimoto, Shun, Oshima, Nobu, Choudhuri, Rajani, Adler, Stephen S., Jagoda, Elaine M., Saito, Keita, Devasahayam, Nallathamby et al. · 2020 · Cancer Research
  19. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B
    Xinyi Li, Jinyuan Dai, Duan Ni, Xinheng He, Hao Zhang, Jian Zhang, Qiang Fu, Yaqin Liu, Shaoyong Lu · 2019 · International Journal of Biological Macromolecules
  20. The biological role of metabolic reprogramming in pancreatic cancer
    Tatsunori Suzuki, Motoyuki Otsuka, Takahiro Seimiya, Takuma Iwata, Takahiro Kishikawa, Kazuhiko Koike · 2020 · MedComm
  21. Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets
    Henriette Berg Andersen, Renata Ialchina, Stine F. Pedersen, Dominika Czaplińska · 2021 · Cancer and Metastasis Reviews
  22. Triple-negative breast tumors are dependent on mutant p53 for growth and survival
    Denada Dibra, Sydney M. Moyer, Adel K. El‐Naggar, Yuan Qi, Xiaoping Su, Guillermina Lozano · 2023 · Proceedings of the National Academy of Sciences
  23. The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
    Haowen Jiang, Jiangbin Ye · 2025 · Seminars in Cancer Biology
  24. Metabolic Features of Cancer Treatment Resistance
    Andrea Viale, Giulio Francesco Draetta · 2016 · Recent results in cancer research/Recent Results in Cancer Research
  25. MicroRNA therapeutics: design of single-stranded miR-216b mimics to target KRAS in pancreatic cancer cells
    Annalisa Ferino, Giulia Miglietta, Raffaella Picco, Stefan Vogel, Jesper Wengel, Luigi Emilio Xodo · 2018 · RNA Biology
  26. Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells
    Arthur Dyer, Benjamin Schoeps, Sally Frost, Philip M. Jakeman, Eleanor M. Scott, Joshua D. Freedman, Egon J. Jacobus, Leonard William Seymour · 2018 · Cancer Research
  27. Protein-Catalyzed Capture Agents
    Heather D. Agnew, Matthew B. Coppock, Matthew N. Idso, Bert T. Lai, JingXin Liang, Amy McCarthy, Carmen M. Warren, James R. Heath · 2019 · Chemical Reviews
  28. Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
    Pilar Espiau-Romera, Sarah Courtois, Beatriz Parejo-Alonso, Patricia Sancho · 2020 · Journal of Clinical Medicine
  29. Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
    Hweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, Mai Chan Lau, Bernett Teck Kwong Lee, Jasmine Tan, Cindy Phua, Florida Toh, Yvonne Nga, Wei Hseun Yeap et al. · 2021 · International Journal of Molecular Sciences
  30. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
    Jasmeet Kaur, Shalmoli Bhattacharyya · 2021 · Frontiers in Oncology
  31. Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
    Saiki, Yuriko, Jiang, Can, Ohmuraya, Masaki, Furukawa, Toru · 2021 · Cancers
  32. Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
    Josef Gillson, Yomna S. Abd El-Aziz, Lionel Yi Wen Leck, Patric J. Jansson, Nick Pavlakis, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2022 · Cancers
  33. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
    Meng Zhang, Haiyan Fan, Shengchao Li · 2015 · Biomedicine & Pharmacotherapy
  34. Targeting molecular addictions in cancer
    Igor Vivanco · 2014 · British Journal of Cancer
  35. Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol
    Chiara Vidoni, Alessandra Ferraresi, Letizia Vallino, Amreen Salwa, Ji Hee Ha, Christian Seca, Beatrice Garavaglia, Danny N. Dhanasekaran, Ciro Isidoro · 2023 · International Journal of Molecular Sciences
  36. Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting
    Guoshuai Xu, Qinghong Zhang, Renjia Cheng, Jun Qu, Wenqiang Li · 2025 · Autophagy
  37. Revisiting the biological role of the Warburg effect: Evolving perspectives on cancer metabolism
    Diego De León-Oliva, Paula González-Prieto, Patricia De Castro-Martinez, Diego Liviu Boaru, Pilar Laguna Hernandez, Oscar Fraile‐Μartinez, Cielo García Montero, Luis G. Guijarro, Laura López-González, Raúl Dı́az et al. · 2025 · Pathology - Research and Practice
  38. NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.
    Zohar Sachs, R. LaRue, Hanh T. Q. Nguyen, K. Sachs, K. E. Noble, N. A. Mohd Hassan, E. Diaz-Flores, S. Rathe, A. Sarver, S. Bendall et al. · 2014 · Blood
  39. Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions
    Andreia V. Pinho, Amanda Mawson, Anthony James Gill, Mehreen Arshi, Max Warmerdam, Marc Giry-Laterrière, Nils Eling, Triyana Lie, Evelyne Kuster, Simone M. R. Camargo et al. · 2016 · Oncotarget
  40. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
    Heather K. Schofield, Jörg Zeller, Carlos E. Espinoza, Christopher J. Halbrook, Annachiara Del Vecchio, Brian Magnuson, Tania Fabo, Ayse Ece Cali Daylan, Ilya Kovalenko, Ho‐Joon Lee et al. · 2018 · JCI Insight
  41. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
    Kai Wang, Graham S. Baldwin, Mehrdad Nikfarjam, Hong Zhen He · 2018 · World Journal of Gastroenterology
  42. Approaches to inhibiting oncogenic K-Ras
    Alemayehu Abebe Gorfe, Kwang‐Jin Cho · 2019 · Small GTPases
  43. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress
    Lisa A. Walter, Yu Lin, Christopher J. Halbrook, Kelly N. Chuh, Lina He, Nichole J. Pedowitz, Anna R. Batt, Caroline K. Brennan, Bangyan L. Stiles, Costas Andreas Lyssiotis et al. · 2019 · Biochemistry
  44. Arginine methylation of ribose-5-phosphate isomerase A senses glucose to promote human colorectal cancer cell survival
    Jizheng Guo, Qixiang Zhang, Ying Su, Xiaochen Lu, Yiping Wang, Miao Yin, Weiguo Hu, Wenyu Wen, Qun‐Ying Lei · 2020 · Science China Life Sciences
  45. Non-coding RNAs rewire cancer metabolism networks
    Xiaorong Lin, Zhi‐Yong Wu, Hai Hu, Man‐Li Luo, Erwei Song · 2021 · Seminars in Cancer Biology
  46. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
    Dimitrios Giannis, Dimitrios Moris, Andrew S. Barbas · 2021 · Cancers
  47. Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets
    Matthias Drosten, Carmen E. Guerra, Mariano Barbacid · 2017 · Cold Spring Harbor Perspectives in Medicine
  48. Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
    Raphaël Peiffer, Yasmine Boumahd, Charlotte Gullo, Rebekah Crake, Elisabeth Letellier, Akeila Bellahcène, Olivier Peulen · 2022 · Cancers
  49. Diabetes and Its Link with Cancer: Providing the Fuel and Spark to Launch an Aggressive Growth Regime
    Sanket Joshi, Menghan Liu, Nigel A. Turner · 2015 · BioMed Research International
  50. Cancer Cell Dormancy in Novel Mouse Models for Reversible Pancreatic Cancer: A Lingering Challenge in the Development of Targeted Therapies
    Wan-Chi Lin, Nirakar Rajbhandari, Kay‐Uwe Wagner · 2014 · Cancer Research
  51. Insulin Regulates Glucose Consumption and Lactate Production through Reactive Oxygen Species and Pyruvate Kinase M2
    Qi Li, Xue Liu, Yu Yin, Jitai Zheng, Chengfei Jiang, Jing Wang, Hua Shen, Chong-Yong Li, Min Wang, L.-Z. Liu et al. · 2014 · Oxidative Medicine and Cellular Longevity
  52. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review)
    Mingzhe Li, Xin Bu, Bolei Cai, Ping Liang, Kai Li, Xuan Qu, Liangliang Shen · 2018 · Oncology Reports
  53. Inhibitor of Differentiation-1 Sustains Mutant KRAS -Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
    Marta Román, Inés López, Elizabeth Guruceaga, Iosune Baraibar, Margarita Ecay, María Collantes, Ernest Nadal, Adrián Vallejo, Silvia Cadenas, Marta Echavarri-de Miguel et al. · 2018 · Cancer Research
  54. Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
    Michael F. Coleman, Alyssa Joy Cozzo, Alexander J. Pfeil, Suhas K. Etigunta, Stephen David Hursting · 2020 · Cancers
  55. Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
    Parash Parajuli, Thien Ly Nguyen, Céline Prunier, Mohammed Shawkat Razzaque, Keli Xu, Azeddine Atfi · 2020 · Life Science Alliance
  56. Advances in Lung Cancer Driver Genes Associated With Brain Metastasis
    Yalin Kang, Yu Tong Jin, Qianxia Li, Xianglin Yuan · 2021 · Frontiers in Oncology
  57. NAD + depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition
    Alexandra M. Moore, Lei Zhou, Jing Cui, Luyi Li, Nanping Wu, Alice C. Yu, Soumya Poddar, Keke Liang, Evan R. Abt, Stephanie Kim et al. · 2021 · Proceedings of the National Academy of Sciences
  58. c-Src facilitates tumorigenesis by phosphorylating and activating G6PD
    Huanhuan Ma, Fengqiong Zhang, Lin Zhou, Tingyan Cao, Dachao Sun, Shixiong Wen, Jinpei Zhu, Zhaoqianyu Xiong, Ming-Tong Tsau, Mei‐Ling Cheng et al. · 2021 · Oncogene
  59. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells
    Yao Shen, Chang-Cyuan Chen, Bo‐Jung Chen, Yu-Ting Wu, Jiun-Ru Juan, Liang-Yun Chen, Yueh-Chun Teng, Yau‐Huei Wei · 2021 · Cells
  60. Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia
    Yusuke Saito, Mariko Kinoshita, Ai Y. Yamada, Sayaka Kawano, Hong‐Shan Liu, Sachiyo Kamimura, Midori Nakagawa, Syun Nagasawa, Tadao Taguchi, Shuhei Yamada et al. · 2021 · Cancer Science
  61. Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
    Hang Sheng Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao · 2022 · 癌症:英文版
  62. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer
    Hazuki E. Miwa, Wade R. Koba, Eugene J. Fine, Orsi Giricz, Paraic A. Kenny, Pamela Stanley · 2013 · Glycobiology
  63. Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
    Bechard, Matthew E., Word, Anna E., Tran, Amanda V., Liu, Xiaojing, Locasale, Jason W., McDonald, Oliver G. · 2018 · Oncogene
  64. Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis
    Bechard, Matthew E., Smalling, Rana, Hayashi, Akimasa, Zhong, Yi, Word, Anna E., Campbell, Sydney L., Tran, Amanda V., Weiss, Vivian L., Iacobuzio-Donahue, Christine, Wellen, Kathryn E. et al. · 2020 · Nature Communications
  65. Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?
    Christopher K. McCann, Emma M. Kerr · 2021 · Cancers
  66. The role of glycans in the mechanobiology of cancer
    Anurag Purushothaman, Mohammad Mohajeri, Tanmay P. Lele · 2023 · Journal of Biological Chemistry
  67. Pathogenesis of Pancreatic Cancer
    Lewis Charles Murtaugh · 2013 · Toxicologic Pathology
  68. RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies
    Bingliang Fang · 2015 · Acta Biochimica et Biophysica Sinica
  69. Breath biopsy for early detection and precision medicine in cancer
    Marc P. van der Schee, Hazel Pinheiro, Edoardo Gaude · 2018 · ecancermedicalscience
  70. β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
    Tzu‐Lei Kuo, Kuang‐Hung Cheng, Yan‐Shen Shan, Li‐Tzong Chen, Wen-Chun Hung · 2018 · Theranostics
  71. Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
    Friederike Inga Nollmann, Dietrich Alexander Ruess · 2020 · Biomedicines
  72. Prognostic implications of metabolism-associated gene signatures in colorectal cancer
    Yandong Miao, Qiutian Li, Jiangtao Wang, Wuxia Quan, Chen Li, Yuan Yang, Denghai Mi · 2020 · PeerJ
  73. TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase
    Ji Hye Kim, Jin‐Young Lee, Young-Ra Cho, So‐Yeon Lee, Gi‐Jun Sung, Dong‐Myung Shin, Kyung‐Chul Choi, Jaekyoung Son · 2021 · Cancers
  74. Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein
    Wenshu Chen, Bryanna Saxton, Mathewos Tessema, Steven A. Belinsky · 2021 · Carcinogenesis
  75. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
    Abudureyimu Tuerhong, Jin Xu, Si Shi, Zhen Tan, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu et al. · 2021 · Cellular and Molecular Life Sciences
  76. Signaling Pathways That Drive18F-FDG Accumulation in Cancer
    Jessica R. Salas, Peter M. Clark · 2022 · Journal of Nuclear Medicine
  77. Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma
    Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
  78. Critical role of oncogenic KRAS in pancreatic cancer (Review).
    Jiang Liu, S. Ji, Chen Liang, Yi Qin, K. Jin, Ding-Kong Liang, W. Xu, S. Shi, Bo Zhang, Liang Liu et al. · 2016 · Molecular Medicine Reports
  79. USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
    Hou, Pingping, Ma, Xingdi, Yang, Zecheng, Zhang, Qiang, Wu, Chang-Jiun, Li, Jun, Tan, Lin, Yao, Wantong, Yan, Liang, Zhou, Xin et al. · 2021 · Genes &amp; Development
  80. p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
    Alessio Butera, Micaela Kalani Roy, Carlotta Zampieri, Eleonora Mammarella, Emanuele Panatta, Gerry Melino, Angelo D’Alessandro, Ivano Amelio · 2022 · Biology Direct
  81. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
    Xuqing Shen, Ningning Niu, Jing Xue · 2022 · Journal of Translational Internal Medicine
  82. Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
    Yukai Huang, Wei‐Chung Cheng, Ting-Ting Kuo, Juan‐Cheng Yang, Yang‐Chang Wu, Heng‐Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze‐Ching Wong, Chih‐Hao Lu et al. · 2024 · Nature Cancer
  83. Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
    Lorey K. Smith, Aparna Dodla Rao, Grant A. McArthur · 2016 · Pharmacological Research
  84. Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
    Yi Ding, Chang Gong, De Huang, Rui Chen, Pinpin Sui, Kevin Lin, Gehao Liang, Lifeng Yuan, Handan Xiang, Junying Chen et al. · 2018 · Nature Communications
  85. Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology
    Heng‐Huan Lee, Ying‐Nai Wang, Mien‐Chie Hung · 2019 · Molecular Aspects of Medicine
  86. Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
    Xinquan Liu, Debadyuti Ghosh · 2019 · International Journal of Nanomedicine
  87. Potassium and Sodium Channels and the Warburg Effect: Biophysical Regulation of Cancer Metabolism
    Jessica Iorio, Giulia Petroni, Claudia Duranti, Elena Lastraioli · 2019 · Bioelectricity
  88. Proteome alterations in pancreatic ductal adenocarcinoma
    Sheng Pan, Teresa A. Brentnall, Ru Chen · 2019 · Cancer Letters
  89. Metabolism remodeling in pancreatic ductal adenocarcinoma
    Jintao Li, Yi-Ping Wang, Miao Yin, Qun‐Ying Lei · 2019 · Cell Stress
  90. Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis
    Guangwei Tian, Guang Li, Peipei Liu, Zihui Wang, Nan Li · 2020 · DNA and Cell Biology
  91. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
    Zhen Tan, Yubin Lei, Jin Xu, Si Shi, Jie Hua, Bo Zhang, Qingcai Meng, Jiang Liu, Yiyin Zhang, Miaoyan Wei et al. · 2020 · Aging
  92. Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
    Andrew M. Waters, Tala O. Khatib, Bjoern Papke, Craig M. Goodwin, G. Aaron Hobbs, J. Nathaniel Diehl, Runying Y. Yang, A. Cole Edwards, Katherine H. Walsh, Rita Sulahian et al. · 2021 · Cell Reports
  93. Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumors
    Rupsa Datta, Sharanya Sivanand, Allison N. Lau, Logan Florek, Anna M. Barbeau, Jeffrey B. Wyckoff, Melissa C. Skala, Matthew G. Vander Heiden · 2022 · Science Advances
  94. Moving the Needle on Precision Medicine in Pancreatic Cancer
    Grainne Mary O'Kane, Maeve Aine Lowery · 2022 · Journal of Clinical Oncology
  95. The hexosamine biosynthesis pathway and O‐Glc NA cylation maintain insulin‐stimulated PI 3K‐ PKB phosphorylation and tumour cell growth after short‐term glucose deprivation
    David R. Jones, Willem‐Jan Keune, Karen E. Anderson, Len Stephens, Phillip T. Hawkins, Nullin Divecha · 2014 · FEBS Journal
  96. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma
    Ashu Shah, Koelina Ganguly, Sanchita Rauth, Shamema S Sheree, Imran Khan, Apar Kishor Ganti, Moorthy Palanimuthu Ponnusamy, Sushil Kumar, Maneesh Jain, Surinder K. Batra · 2024 · Drug Resistance Updates
  97. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation
    James La Porta, Rodrigo Matus‐Nicodemos, Anibal Valentín-Acevedo, Lori R. Covey · 2016 · PLoS ONE
  98. Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
    Katherine Eason, Anguraj Sadanandam · 2016 · Cancer Research
  99. Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
    Tatsuyuki Chiyoda, Peter C. Hart, Mark A. Eckert, Stephanie M. McGregor, Ricardo R. Lastra, Ryuji Hamamoto, Yusuke Nakamura, S. Diane Yamada, Olufunmilayo Ibironke Olopade, Ernst R. Lengyel et al. · 2017 · Cancer Prevention Research
  100. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer
    Rachel L. Dittmar, Suyu Liu, Mei-Chee Tai, Kimal Rajapakshe, Ying Huang, Gary Longton, Christine DeCapite, Mark W. Hurd, Pamela L. Paris, Kimberly Saunders Kirkwood et al. · 2021 · Cancer Prevention Research